Author:
Klapper W,Stoecklein H,Zeynalova S,Ott G,Kosari F,Rosenwald A,Loeffler M,Trümper L,Pfreundschuh M,Siebert Reiner
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference18 articles.
1. Jaffe E, Harris N, Stein H, Vardiman JW . Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tissues. IARC Press: Lyon, France, 2001, pp 171–174.
2. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379–391.
3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242.
4. Engelhard M, Brittinger G, Huhn D, Gerhartz HH, Meusers P, Siegert W et al. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 1997; 89: 2291–2297.
5. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987–994.
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献